Funding, News and Announcements

The Weston Brain Institute is delighted to launch our Canada: ALS 2016 program to support translational research of outstanding scientific merit that will accelerate the development of safe and effective therapeutics for amyotrophic lateral sclerosis (ALS).

Program Information Session

Tuesday, March 22^nd, 2:00pm EDT

REGISTER HERE

Letter of Intent deadline

Tuesday, April 19^th, 2:00pm EDT

APPLY HERE

Visit our website for more information

Funding & Eligibility

Applicants may apply to both the Canada: ALS 2016 Rapid Response program and Canada: ALS 2016 Transformational Research program.

Canada: ALS 2016 Rapid Response

Canada: ALS 2016 Transformational Research

· Seed funding for novel, high-risk, high-reward research

· Up to $150,000 and 18 months per project

· Preliminary data is optional

· Principal Applicants must be at the level of Postdoctoral Fellow or higher

· Applicants can only appear once as either the Principal Applicant or the Administrative Supervisor

· Larger, longer grants that significantly advance preclinical research

· Up to  $1.5 million and 3 years per project

· Must have excellent preliminary data

· Principal Applicants must be at the level of Assistant Professor or higher

See the Request for Applications (RFA) and the Program Details for more information.

Program Information Session

The Weston Brain Institute will be holding an online Information Session on Tuesday, March 22^ndat 2:00pm EDT to provide you with comprehensive information on the application process and an opportunity for open questions.   REGISTER HERE

The Institute welcomes inquiries about our funding programs at neuro@weston.ca or 416-935-4056.

Weston Brain Institute